...
【24h】

Analysis of causes of death in liver transplant recipients who survived more than 3 years.

机译:存活3年以上的肝移植受者的死亡原因分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Few studies have examined causes of death in long-term survivors of orthotopic liver transplantation (OLT). We reviewed causes of death among 299 adult liver transplant recipients who survived more than 3 years after OLT at 2 centers. Thirty-eight of the 299 patients subsequently died. Nonhepatic causes accounted for 22 of 38 late deaths (58%). Death caused by malignancies occurred in 9 patients between 3.3 and 8.0 years after OLT. Eight patients died of cardiovascular complications. The 6 patients who died of myocardial infarction had risk factors for coronary artery disease. Hepatic failure caused by recurrent liver disease or chronic rejection accounted for 16 of 38 late deaths (42%). These 16 patients were younger than patients who died of nonhepatic complications (mean ages, 50.7 v 62.1 years; P =.001). However, the mean interval between OLT and death was similar among patients who died of nonhepatic versus hepatic causes. Nine patients had recurrent liver disease leading to death, and 8 of 9 patients had recurrent chronic hepatitis C virus (HCV) infection. Chronic rejection resulting in graft failure and death occurred in 7 patients. In summary, de novo malignancies and cardiovascular complications accounted for more than half the late deaths. Patients who died of nonhepatic causes were significantly older than patients who died of hepatic causes. Chronic rejection and recurrent HCV infection accounted for the majority of hepatic causes of death. With longer follow-up, graft failure resulting from recurrent HCV infection will become the major cause of death in late survivors.
机译:很少有研究检查原位肝移植(OLT)长期存活者的死亡原因。我们回顾了在2个中心的OLT存活超过3年的299名成年肝移植受者中的死亡原因。 299名患者中有38名随后死亡。非肝病原因占38例晚期死亡中的22例(58%)。在OLT术后3.3至8.0年之间,有9例患者因恶性肿瘤而死亡。 8例患者死于心血管并发症。死于心肌梗塞的6例患者有冠心病的危险因素。复发性肝病或慢性排斥反应引起的肝衰竭占38例晚期死亡中的16例(42%)。这16例患者比因非肝并发症死亡的患者年轻(平均年龄为50.7 v 62.1岁; P = .001)。但是,因非肝病原因和肝病原因而死亡的患者中,OLT与死亡之间的平均间隔相似。 9例患者患有复发性肝病导致死亡,9例患者中的8例患有慢性C型肝炎病毒(HCV)复发性感染。 7例患者发生了慢性排斥反应,导致移植失败和死亡。总之,新生恶性肿瘤和心血管并发症占晚期死亡的一半以上。死于非肝病的患者比死于肝病的患者年龄大得多。慢性排斥反应和HCV反复感染是造成肝脏死亡的主要原因。随着随访时间的延长,由于HCV反复感染导致的移植失败将成为晚期幸存者死亡的主要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号